Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario W Kramer

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
World Journal of Urology|August 11, 2020
New computed tomographic predictors of complicated perioperative course of 17.5F mini-percutaneous nephrolithotomy (mini-PNL)Tomasz Ozimek, Jan M Laturnus, Carolin Gohlke, et al.
The Prostate|November 17, 2007
Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancerAxel S Merseburger, Mario W Kramer, Jörg Hennenlotter, et al.
BMC Urology|June 15, 2022
The dilemma of 12/14F ureteral access sheath (UAS) usage: a case control studyTomasz Ozimek, Judith R Wiessmeyer, Julian P Struck, et al.
World Journal of Urology|May 6, 2011
Current evidence for transurethral laser therapy of non-muscle invasive bladder cancerMario W Kramer, Thorsten Bach, Mathias Wolters, et al.
Molecular Biology Reports|December 8, 2022
The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemicFabian Sehn, Hartwig Büttner, Beate Godau, et al.
Urologia Internationalis|February 26, 2020
The Impact of Endourological Experience on Flexible Ureteroscopy Outcomes and Performance at Different Levels of Expertise: Retrospective Multifactorial AnalysisTomasz Ozimek, Mario W Kramer, Marie C Hupe, et al.
Targeted Oncology|September 19, 2014
Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinomaInga Peters, Natalia Dubrowinskaja, Hossein Tezval, et al.
Advances in Therapy|October 25, 2013
Age distribution for partial and radical nephrectomy: whose nephrons are being spared?Christoph von Klot, Thomas R Herrmann, Gerd Wegener, et al.
Cancer|October 21, 2010
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosisMario W Kramer, Diogo O Escudero, Soum D Lokeshwar, et al.
Rare Tumors|July 9, 2014
Synovial sarcoma of the kidney in a young patient with a review of the literatureMahmoud Abbas, Maximilian E Dämmrich, Peter Braubach, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
World Journal of Urology|August 11, 2020
New computed tomographic predictors of complicated perioperative course of 17.5F mini-percutaneous nephrolithotomy (mini-PNL)Tomasz Ozimek, Jan M Laturnus, Carolin Gohlke, et al.
The Prostate|November 17, 2007
Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancerAxel S Merseburger, Mario W Kramer, Jörg Hennenlotter, et al.
BMC Urology|June 15, 2022
The dilemma of 12/14F ureteral access sheath (UAS) usage: a case control studyTomasz Ozimek, Judith R Wiessmeyer, Julian P Struck, et al.
World Journal of Urology|May 6, 2011
Current evidence for transurethral laser therapy of non-muscle invasive bladder cancerMario W Kramer, Thorsten Bach, Mathias Wolters, et al.
Molecular Biology Reports|December 8, 2022
The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemicFabian Sehn, Hartwig Büttner, Beate Godau, et al.
Urologia Internationalis|February 26, 2020
The Impact of Endourological Experience on Flexible Ureteroscopy Outcomes and Performance at Different Levels of Expertise: Retrospective Multifactorial AnalysisTomasz Ozimek, Mario W Kramer, Marie C Hupe, et al.
Targeted Oncology|September 19, 2014
Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinomaInga Peters, Natalia Dubrowinskaja, Hossein Tezval, et al.
Advances in Therapy|October 25, 2013
Age distribution for partial and radical nephrectomy: whose nephrons are being spared?Christoph von Klot, Thomas R Herrmann, Gerd Wegener, et al.
Cancer|October 21, 2010
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosisMario W Kramer, Diogo O Escudero, Soum D Lokeshwar, et al.
Rare Tumors|July 9, 2014
Synovial sarcoma of the kidney in a young patient with a review of the literatureMahmoud Abbas, Maximilian E Dämmrich, Peter Braubach, et al.
Pageof 8